Cargando…

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis

BACKGROUND: Long non coding RNAs (lncRNAs) are RNA molecules longer than 200 nucleotides that are not translated into proteins, but regulate the transcription of genes involved in different cellular processes, including cancer. Epidemiological analyses have demonstrated that parous women have a decr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barton, Maria, Santucci-Pereira, Julia, Vaccaro, Olivia G., Nguyen, Theresa, Su, Yanrong, Russo, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813071/ https://www.ncbi.nlm.nih.gov/pubmed/31646972 http://dx.doi.org/10.1186/s12885-019-6179-y

Ejemplares similares

Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
por: Su, Yanrong, et al.
Publicado: (2018)

Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis
por: Singh, R, et al.
Publicado: (2016)

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

Development and characterization of two human triple‐negative breast cancer cell lines with highly tumorigenic and metastatic capabilities
por: Su, Yanrong, et al.
Publicado: (2016)

Comparison of BRCA1 Expression between Triple-Negative and Luminal Breast Tumors
por: Darbeheshti, Farzaneh, et al.
Publicado: (2018)

BC200 RNA: An Emerging Therapeutic Target and Diagnostic Marker for Human Cancer
por: Shin, Heegwon, et al.
Publicado: (2018)

BC200 (BCYRN1) – The shortest, long, non-coding RNA associated with cancer
por: Samson, J., et al.
Publicado: (2018)

Functional analysis of RNA motifs essential for BC200 RNA-mediated translational regulation
por: Jang, Seonghui, et al.
Publicado: (2020)

The Long Non-Coding BC200 Is a Novel Circulating Biomarker of Parathyroid Carcinoma
por: Morotti, Annamaria, et al.
Publicado: (2022)

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
por: Khadela, Avinash, et al.
Publicado: (2022)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

Cephalometric Characteristics in Skulls with Artificial Deformation in a Pre-Columbian Civilization of the Peruvian Andes (Chavin Civilization 900 B.C. to 200 B.C.)
por: Pérez-Vargas, Fernando, et al.
Publicado: (2021)

Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2021)

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2012)

Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer
por: El Hachem, Georges, et al.
Publicado: (2019)

DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer
por: Sigin, Vladimir O., et al.
Publicado: (2023)

Effect of lncRNA-BC200 on proliferation and migration of liver cancer cells in vitro and in vivo
por: Tan, Ni, et al.
Publicado: (2020)

Overexpression of BcERF3 increases the biosynthesis of saikosaponins in Bupleurum chinense
por: Han, Wenjing, et al.
Publicado: (2022)

Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis
por: Mellor, Paul, et al.
Publicado: (2022)

HOXB7 Overexpression Leads Triple-Negative Breast Cancer Cells to a Less Aggressive Phenotype
por: de Bessa Garcia, Simone Aparecida, et al.
Publicado: (2021)

Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences
por: Tayyari, Fariba, et al.
Publicado: (2018)

Common profiles of Notch signaling differentiate disease-free survival in luminal type A and triple negative breast cancer
por: Orzechowska, Magdalena, et al.
Publicado: (2016)

Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer
por: Millar, Ewan KA, et al.
Publicado: (2020)

Flagella Overexpression Attenuates Salmonella Pathogenesis
por: Yang, Xinghong, et al.
Publicado: (2012)

MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype
por: Sugita, Bruna M., et al.
Publicado: (2022)

Comprehensive analysis of the BC200 ribonucleoprotein reveals a reciprocal regulatory function with CSDE1/UNR
por: Booy, Evan P, et al.
Publicado: (2018)

miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22
por: Li, Xiaodong, et al.
Publicado: (2017)

The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation
por: Booy, Evan P., et al.
Publicado: (2017)

The noncoding RNA BC200 associates with polysomes to positively regulate mRNA translation in tumor cells
por: Booy, Evan P., et al.
Publicado: (2020)

BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients
por: Incorvaia, Lorena, et al.
Publicado: (2020)

Overexpression of MicroRNA-200c Predicts Poor Outcome in Patients with PR-Negative Breast Cancer
por: Tuomarila, Marie, et al.
Publicado: (2014)

Molecular Pathways Involved in Pregnancy-Induced Prevention Against Breast Cancer
por: Barton, Maria, et al.
Publicado: (2014)

The contribution of luminance and chromatic channels to color assimilation
por: Otazu, Xavier, et al.
Publicado: (2022)

Overexpression of FRAT1 protein is closely related to triple-negative breast cancer
por: Nam, Sang Eun, et al.
Publicado: (2022)

High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
por: Jin, Zining, et al.
Publicado: (2022)

Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231
por: Garbar, Christian, et al.
Publicado: (2017)

BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
por: Lips, Esther H., et al.
Publicado: (2020)

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
por: Mouron, Silvana, et al.
Publicado: (2021)

Release of Luminal Exosomes Contributes to TLR4-Mediated Epithelial Antimicrobial Defense
por: Hu, Guoku, et al.
Publicado: (2013)

MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells
por: Sánchez-Cid, Lourdes, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s8pnc27hog6caiiqe6ugk8r3ru